In summary, identifying P/LP variants in COL4A3, COL4A4, or COL4A5 during reproductive carrier screening provides an important opportunity for early clinical intervention for Alport syndrome heterozygotes and their families. The gene discussed is COL4A5; the disease is Alport syndrome.